growth in sales of non-Covid drugs to boost Indian pharma market

The Indian pharmaceutical market (IPM) is expected to report 11-12 per cent year on year growth in the FY 2023 mainly pushed by price rise and further recovery in non-Covid drugs volumes. Building on to the recovery seen in…